Sandbox 54321
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
== Structure == | == Structure == | ||
| - | <scene name='74/745973/Lisinopril_zinc/1'>Lisinopril</scene>is a synthetic angiotensin-converting enzyme inhibitor (ACE inhibitors) with molecular formula of C21+H31+N3+O5, empirical formula of C21+H31+N3+O5*2H2O, and average molecular weight of 405.495 g/mol. It is primarily used for the treatment of hypertension | + | <scene name='74/745973/Lisinopril_zinc/1'>Lisinopril</scene>is a synthetic angiotensin-converting enzyme inhibitor (ACE inhibitors) with molecular formula of C21+H31+N3+O5, empirical formula of C21+H31+N3+O5*2H2O, and average molecular weight of 405.495 g/mol. It is primarily used for the treatment of hypertension. Lisinopril is typically in the trans isometric form because it has a lower steric repulsion between the hydroxyl and carboxyl groups than the cis conformation and is biologically active in this form (Bouabdallah).Lisinopril has a benzene ring and from there it has a 4-carbon amide chain where it branches of into a carboxylic acid group one way and a secondary amide group the other way which connects to the rest of the molecule. From the secondary amide, the molecule branches into a 5-carbon amine with a primary amide at the end. The other branch from the secondary amide has a ketone bonded to a nitrogen in a 4-carbon ring. From this carbon ring, there is a carboxylic acid group. |
== Relevance == | == Relevance == | ||
| Line 17: | Line 17: | ||
== Mechanism == | == Mechanism == | ||
| - | + | Lisinopril is a drug used mainly to treat hypertension but also to reduce the risk of long-term damage and death in patients suffering from heart failure. Lisinopril controls blood pressure by inhibiting the angiotensin converting enzyme (ACE). By inhibiting ACE, it inevitably prevents the body from synthesizing angiotensin II. | |
| + | Without the surplus of angiotensin II being made, the blood pressure in the body lowers due to the increase in the ratio of vasodilating angiotensin I to vasoconstricting angiotensin II (Helen, 2016). | ||
</StructureSection> | </StructureSection> | ||
| + | |||
== References == | == References == | ||
<references/> | <references/> | ||
| + | |||
| + | Helen, Allen(2016). Lisinopril: Lisinopril ACE inhibitor. Patient. Retrieved from: http://patient.info/medicine/lisinopril-an-ace-inhibitor-zestril | ||
| + | |||
| + | |||
| + | Natesh, R., Schwager, S.L.U., Sturrock, E.D., Acharya, K. R. (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.Nature 421, 551-554 doi:10.1038/nature01370 | ||
| + | |||
| + | National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119 (accessed Nov. 12, 2016). | ||
Revision as of 17:20, 12 November 2016
==Your Heading Here (maybe something like 'Structure')== 0
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
Helen, Allen(2016). Lisinopril: Lisinopril ACE inhibitor. Patient. Retrieved from: http://patient.info/medicine/lisinopril-an-ace-inhibitor-zestril
Natesh, R., Schwager, S.L.U., Sturrock, E.D., Acharya, K. R. (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.Nature 421, 551-554 doi:10.1038/nature01370
National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119 (accessed Nov. 12, 2016).
